Coherus Oncology
CHRS
CHRS
135 hedge funds and large institutions have $143M invested in Coherus Oncology in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $198M → $143M (-$54.8M)
32% less call options, than puts
Call options by funds: $219K | Put options by funds: $321K
Holders
135
Holding in Top 10
–
Calls
$219K
Puts
$321K
Top Buyers
| 1 | +$1.82M | |
| 2 | +$1.73M | |
| 3 | +$1.25M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$905K |
| 5 |
BlackRock
New York
|
+$903K |
Top Sellers
| 1 | -$3.72M | |
| 2 | -$2.7M | |
| 3 | -$1.92M | |
| 4 |
Millennium Management
New York
|
-$1.11M |
| 5 |
Two Sigma Investments
New York
|
-$1.09M |